[["NKX2.1 mutations", "have been identified in", "patients displaying complete or partial brain-lung-thyroid syndrome"], ["brain-lung-thyroid syndrome", "can include", "benign hereditary chorea (BHC)"], ["brain-lung-thyroid syndrome", "can include", "hypothyroidism"], ["brain-lung-thyroid syndrome", "can include", "lung disease"], ["the goal of the study", "was to determine", "if MLPA could improve detection rate of NKX2.1 mutations"], ["MLPA", "increased the detection rate by", "50%"], ["direct sequencing", "revealed", "two heterozygous mutations"], ["MLPA", "identified", "two further heterozygous NKX2.1 gene deletions"], ["all patients with gene deletions", "were affected by", "BHC and congenital hypothyroidism"], ["MLPA", "should be considered as", "a complementary tool in patients with brain-lung-thyroid syndrome"], ["all patients with an NKX2.1 mutation", "had", "BHC and congenital hypothyroidism"], ["the high prevalence of signs", "is associated with", "defective NKX2.1 alleles"]]